| abstract |
The present invention addresses the problem of providing a GLP-1 secretagogue, which is an incretin hormone-related drug that is relatively inexpensive and has excellent safety, and which can promote the secretion of GLP-1 without having sucrose as an essential constituent. The problem is solved by a GLP-1 secretagogue characterized by comprising D-psicose as an active ingredient. |